Methylprednisolone acetate

National NHS prescribing (Prescription Cost Analysis) · Drugs used in rheumatic diseases and gout

Data updated March 2026

Methylprednisolone acetate was ranked 221st of 1,794 medicines by items in March 2026, with 68,423 items, up 39.2% on a year earlier.

68,423items

Dispensed in March 2026

NHSBSA Prescription Cost Analysis

£338,729

Net ingredient cost · March 2026

NHSBSA PCA

715,216items

Dispensed in the last 12 months

NHSBSA PCA

Figure 1. Methylprednisolone acetate: national items dispensed by month

Source: NHSBSA Prescription Cost Analysis, to March 2026

Download CSV

Embed this chart

<iframe src="https://pharmainsight.co.uk/embed/medicines/methylprednisolone-acetate-1001022k0" width="100%" height="280" style="border:0" loading="lazy" title="Methylprednisolone acetate: NHS prescribing in England — PharmaInsight"></iframe>

Top presentations, March 2026

The individual products dispensed under Methylprednisolone acetate, by items this month.

Presentations of Methylprednisolone acetate, March 2026
Presentation	Items	Net ingredient cost
Depo-Medrone 40mg/1ml suspension for injection vials	36,470	£146,206
Depo-Medrone with Lidocaine inj 1ml vials	17,105	£80,775
Depo-Medrone with Lidocaine inj 2ml vials	8,761	£68,102
Depo-Medrone 80mg/2ml suspension for injection vials	5,718	£39,921
Depo-Medrone 120mg/3ml suspension for injection vials	369	£3,724

Compare Methylprednisolone acetate with

Other medicines in the same BNF section, by prescribing volume.